Single-molecule Proteomics
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
90
NCT04969315
TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jun 23, 2023
Completion: Dec 31, 2027
Loading map...